The table below shows AVANOS MEDICAL, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$182.20M
$177.80M
$175.00M
$167.50M
$170.40M
$171.70M
Cost of revenue
$88.00M
$91.80M
$82.90M
$77.70M
$77.50M
$76.10M
Gross profit
$94.20M
$86.00M
$92.10M
$89.80M
$92.90M
$95.60M
R&D
$5.20M
$6.00M
$5.80M
$5.40M
$7.20M
$6.30M
AVNS annual revenue (10-K history)
AVANOS MEDICAL, INC. reported annual revenue of $701.20M for fiscal year 2025. That is up 1.9% from $687.80M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $566.20M (FY 2016) to $701.20M. Figures come from the company's audited annual reports as filed with the SEC.
